| HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US |
FUTURE ONCOLOGY
Volume 4 #10/11 February/March 1999
State-of-the-Art in the Management of Cancer
KIDNEY CANCER-PART II
Molecular Markers, Diagnosis, Staging and prognosis and Current TReatment Modalities
Major Types of Kidney Cancer
Renal Cell Carcinoma (RCC)
Urothelial Carcinoma of the Renal Pelvis, Ureter, and Calyces
Wilms' Tumor
Molecular Markers
Hereditary Markers
Markers Associated with Sporadic RCC
Diagnosis of Kidney Cancer
Staging of Kidney Cancer
Renal Cell Carcinoma
Transitional Cell Carcinoma of the Renal Pelvis and Ureter
Wilms’ Tumor
Prognosis
Current Approaches Used in the Treatment of Kidney Cancer
Surgery
Radiation Therapy
Immunotherapy
- Recombinant IL-2
- Combination immunotherapy
- Tumor infiltrating lymphocytes
Chemotherapy
Chemoimmunotherapy
Treatment Approaches by Kidney Cancer Type and Stage
Renal Cell Carcinoma
Transitional Cell Tumor of the Renal Pelvis and Ureter
Wilms’ Tumor
Meeting Coverage
UPDATE ON OVARIAN CANCER
From the 90th Annual Meeting of the American Association for Cancer Research (AACR)
Philadelphia, PA, April 10-14, 1999
Genetics of Ovarian Cancer
Metastatic Disease
Angiogenesis
Carboxyamido-triazole (CAI)
p53
- E1B-deleted adenovirus
HER2/neu
PI3K Signaling Pathway
BRCA-1 Expression and Familial Ovarian Cancer
Borderline Ovarian Cancer